Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus

Abstract

Tacrolimus monotherapy is an effective and safe option for the treatment of MN with stable renal function. Relapses are frequent in patients with PR and can be partially prevented by a longer tapering period.